| Vasopressin versus norepinephrine infusion in patients with septic shock JA Russell, KR Walley, J Singer, AC Gordon, PC Hébert, DJ Cooper, ... New England Journal of Medicine 358 (9), 877-887, 2008 | 1843 | 2008 |
| Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality JH Boyd, J Forbes, T Nakada, KR Walley, JA Russell Critical care medicine 39 (2), 259-265, 2011 | 1775 | 2011 |
| Management of sepsis JA Russell New England Journal of Medicine 355 (16), 1699-1713, 2006 | 1620 | 2006 |
| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1340 | 1994 |
| Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1208 | 1995 |
| The effects of ibuprofen on the physiology and survival of patients with sepsis GR Bernard, AP Wheeler, JA Russell, R Schein, WR Summer, ... New England Journal of Medicine 336 (13), 912-918, 1997 | 1034 | 1997 |
| Physiology of vasopressin relevant to management of septic shock CL Holmes, BM Patel, JA Russell, KR Walley Chest 120 (3), 989-1002, 2001 | 782 | 2001 |
| Beneficial effects of short-term vasopressin infusion during severe septic shock BM Patel, DR Chittock, JA Russell, KR Walley The Journal of the American Society of Anesthesiologists 96 (3), 576-582, 2002 | 756 | 2002 |
| Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model P von Dadelszen, B Payne, J Li, JM Ansermino, FB Pipkin, AM Côté, ... The Lancet 377 (9761), 219-227, 2011 | 687 | 2011 |
| A trial of antioxidants N-acetylcysteine and procysteine in ARDS GR Bernard, AP Wheeler, MM Arons, PE Morris, HL Paz, JA Russell, ... Chest 112 (1), 164-172, 1997 | 577 | 1997 |
| Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care … D Annane, SM Pastores, B Rochwerg, W Arlt, RA Balk, A Beishuizen, ... Intensive care medicine 43 (12), 1751-1763, 2017 | 567 | 2017 |
| Bicarbonate does not improve hemodynamics in critically III patients who have lactic acidosis: a prospective, controlled clinical study DJ Cooper, KR Walley, BR Wiggs, JA Russell Annals of internal medicine 112 (7), 492-498, 1990 | 551 | 1990 |
| Early changes in organ function predict eventual survival in severe sepsis MM Levy, WL Macias, JL Vincent, JA Russell, E Silva, B Trzaskoma, ... Critical care medicine 33 (10), 2194-2201, 2005 | 480 | 2005 |
| Identification of the critical oxygen delivery for anaerobic metabolism in critically III septic and nonseptic humans JJ Ronco, JC Fenwick, MG Tweeddale, BR Wiggs, PT Phang, DJ Cooper, ... Jama 270 (14), 1724-1730, 1993 | 463 | 1993 |
| Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569] GT Kinasewitz, SB Yan, B Basson, P Comp, JA Russell, A Cariou, SL Um, ... Critical Care 8 (2), 1-9, 2004 | 452 | 2004 |
| The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series CL Holmes, KR Walley, DR Chittock, T Lehman, JA Russell Intensive care medicine 27 (8), 1416-1421, 2001 | 409 | 2001 |
| Engineering of fibrin-based functional and implantable small-diameter blood vessels DD Swartz, JA Russell, ST Andreadis American Journal of Physiology-Heart and Circulatory Physiology 288 (3 …, 2005 | 369 | 2005 |
| Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis GR Bernard, EW Ely, TJ Wright, J Fraiz, JE Stasek Jr, JA Russell, I Mayers, ... Critical care medicine 29 (11), 2051-2059, 2001 | 366 | 2001 |
| Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy CL Holmes, JA Russell, KR Walley Chest 124 (3), 1103-1115, 2003 | 351 | 2003 |
| PCSK9 is a critical regulator of the innate immune response and septic shock outcome KR Walley, KR Thain, JA Russell, MP Reilly, NJ Meyer, JF Ferguson, ... Science translational medicine 6 (258), 258ra143-258ra143, 2014 | 324 | 2014 |
